Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
Denis Oduor, Nairobi County Blood Services Coordinator at Nairobi City County, shared a post on LinkedIn:
“The Blood That Never Arrived
It was 2:17 a.m.
A young mother had just delivered twins. Moments later, she began to hemorrhage.
The doctors knew exactly what to do. The nurses were ready. The operating theatre was prepared.
But one thing was missing.
Blood.
Not because no one wanted to donate.
Not because the clinicians delayed.
Not because the science failed.
The nearest blood unit was hours away.
The cold chain had been interrupted. Testing had to be completed elsewhere. Transport was delayed. By the time compatible blood arrived, the opportunity to save a life had narrowed dramatically.
Blood is unlike any other medical product.
It cannot be manufactured in a factory.
It cannot be ordered overnight.
It depends on generous donors, sophisticated testing, uninterrupted cold-chain systems, skilled personnel, reliable transport, and functioning blood establishments.
When any link in this chain breaks, the patient pays the price.
This raises an uncomfortable but necessary question:
Should every healthcare system continue depending on a biological product that can become unavailable precisely when emergencies increase?
Perhaps the conversation should no longer focus only on collecting more blood.
Perhaps it is time to invest equally in:
- Strong county blood establishments and satellite blood banks.
- Reliable cold-chain and transport logistics.
- Modern component processing technologies.
- Patient Blood Management (PBM) to reduce avoidable transfusions.
- Alternatives that minimize blood use where clinically appropriate.
- Sustainable donor retention rather than emergency donor appeals.
Blood will always remain indispensable. But resilient health systems should ensure that patients are not left waiting for a product whose availability depends on so many vulnerable links.
What policy reforms should governments prioritize to make blood available whenever and wherever patients need it?
I invite clinicians, transfusion specialists, policymakers, hospital leaders, researchers, donors, and development partners to share their perspectives. The next life saved may depend on the ideas we discuss today.”

Stay updated with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C